Investment Analysts’ Upgrades for November 6th (AZN, BEAM, BLMN, BURBY, CAPL, CE, CL, CLX, CNOB, EDIT)

Investment Analysts’ upgrades for Wednesday, November 6th:

AstraZeneca (NASDAQ:AZN) was upgraded by analysts at Deutsche Bank Aktiengesellschaft from a sell rating to a hold rating.

Beam Therapeutics (NASDAQ:BEAM) was upgraded by analysts at Leerink Partners from a market perform rating to an outperform rating. They currently have $39.00 price target on the stock, up from their previous price target of $27.00.

Bloomin’ Brands (NASDAQ:BLMN) was upgraded by analysts at StockNews.com from a sell rating to a hold rating.

Burberry Group (OTCMKTS:BURBY) was upgraded by analysts at Royal Bank of Canada from a sector perform rating to an outperform rating.

CrossAmerica Partners (NYSE:CAPL) was upgraded by analysts at StockNews.com from a buy rating to a strong-buy rating.

Celanese (NYSE:CE) was upgraded by analysts at Deutsche Bank Aktiengesellschaft from a hold rating to a buy rating. Deutsche Bank Aktiengesellschaft currently has $110.00 price target on the stock, down from their previous price target of $135.00.

Colgate-Palmolive (NYSE:CL) was upgraded by analysts at StockNews.com from a hold rating to a buy rating.

Clorox (NYSE:CLX) was upgraded by analysts at TD Cowen from a sell rating to a hold rating. They currently have $170.00 target price on the stock, up from their previous target price of $155.00.

ConnectOne Bancorp (NASDAQ:CNOB) was upgraded by analysts at StockNews.com from a sell rating to a hold rating.

Editas Medicine (NASDAQ:EDIT) was upgraded by analysts at Evercore ISI from an in-line rating to an outperform rating.

Enbridge (NYSE:ENB) (TSE:ENB) was upgraded by analysts at Wells Fargo & Company from an underweight rating to an equal weight rating.

Fomento Económico Mexicano (NYSE:FMX) was upgraded by analysts at StockNews.com from a hold rating to a buy rating.

Home Bancshares, Inc. (Conway, AR) (NYSE:HOMB) was upgraded by analysts at StockNews.com from a sell rating to a hold rating.

Humana (NYSE:HUM) was upgraded by analysts at Bank of America Co. from an underperform rating to a neutral rating. Bank of America Co. currently has $308.00 target price on the stock, up from their previous target price of $247.00.

James Hardie Industries (NYSE:JHX) was upgraded by analysts at JPMorgan Chase & Co. from a neutral rating to an overweight rating.

Masimo (NASDAQ:MASI) was upgraded by analysts at Raymond James from a market perform rating to an outperform rating. They currently have $170.00 target price on the stock.

Nordic American Tankers (NYSE:NAT) was upgraded by analysts at StockNews.com from a sell rating to a hold rating.

Natera (NASDAQ:NTRA) was upgraded by analysts at StockNews.com from a sell rating to a hold rating.

One Stop Systems (NASDAQ:OSS) was upgraded by analysts at Alliance Global Partners from a neutral rating to a buy rating. The firm currently has $4.50 price target on the stock, up from their previous price target of $3.25.

Revolve Group (NYSE:RVLV) was upgraded by analysts at Barclays PLC from an underweight rating to an equal weight rating. They currently have $25.00 target price on the stock, up from their previous target price of $17.00.

Solaris Energy Infrastructure (NASDAQ:SEI) was upgraded by analysts at Pickering Energy Partners from a neutral rating to an outperform rating.

Snowflake (NYSE:SNOW) was upgraded by analysts at Monness Crespi & Hardt from a neutral rating to a buy rating. They currently have $140.00 price target on the stock.

Texas Capital Bancshares (NASDAQ:TCBI) was upgraded by analysts at StockNews.com from a sell rating to a hold rating.

Sixth Street Specialty Lending (NYSE:TSLX) was upgraded by analysts at LADENBURG THALM/SH SH from a neutral rating to a buy rating. LADENBURG THALM/SH SH currently has $21.00 price target on the stock.

United Parcel Service (NYSE:UPS) was upgraded by analysts at StockNews.com from a hold rating to a buy rating.

Westwood Holdings Group (NYSE:WHG) was upgraded by analysts at StockNews.com from a hold rating to a buy rating.

DENTSPLY SIRONA (NASDAQ:XRAY) was upgraded by analysts at StockNews.com from a hold rating to a buy rating.